Man Group’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $198M | Sell |
935,759
-85,036
| -8% | -$18.3M | 0.36% | 47 |
|
|
2025
Q4 | $210M | Sell |
1,020,795
-584,554
| -36% | -$110M | 0.36% | 58 |
|
|
2025
Q3 | $252M | Buy |
1,605,349
+331,783
| +26% | +$51.3M | 0.44% | 34 |
|
|
2025
Q2 | $214M | Buy |
1,273,566
+180,315
| +16% | +$26.8M | 0.41% | 38 |
|
|
2025
Q1 | $151M | Buy |
1,093,251
+306,961
| +39% | +$39.1M | 0.38% | 39 |
|
|
2024
Q4 | $93M | Sell |
786,290
-43,541
| -5% | -$5.08M | 0.24% | 90 |
|
|
2024
Q3 | $91.7M | Sell |
829,831
-164,719
| -17% | -$17.2M | 0.24% | 91 |
|
|
2024
Q2 | $97.8M | Sell |
994,550
-393,796
| -28% | -$40.1M | 0.25% | 81 |
|
|
2024
Q1 | $155M | Buy |
1,388,346
+132,813
| +11% | +$14.3M | 0.39% | 39 |
|
|
2023
Q4 | $127M | Buy |
+1,255,533
| New | +$125M | 0.35% | 46 |
|
|
2023
Q3 | – | Sell |
-1,945,048
| Closed | -$176M | – | 34 |
|
|
2023
Q2 | $184M | Buy |
+1,945,048
| New | +$164M | 0.57% | 22 |
|
|
2023
Q1 | – | Sell |
-1,477,702
| Closed | -$111M | – | 22 |
|
|
2022
Q4 | $114M | Buy |
1,477,702
+599,698
| +68% | +$45.6M | 0.41% | 39 |
|
|
2022
Q3 | $58.5M | Buy |
+878,004
| New | +$55.7M | 0.27% | 75 |
|
|
2022
Q2 | – | Sell |
-1,068,364
| Closed | -$60.7M | – | 239 |
|
|
2022
Q1 | $60.6M | Sell |
1,068,364
-518,640
| -33% | -$27.8M | 0.21% | 105 |
|
|
2021
Q4 | $81.7M | Buy |
1,587,004
+1,274,075
| +407% | +$62.5M | 0.26% | 77 |
|
|
2021
Q3 | $15.5M | Buy |
312,929
+6,851
| +2% | +$372K | 0.05% | 428 |
|
|
2021
Q2 | $17.5M | Sell |
306,078
-233,080
| -43% | -$13.6M | 0.06% | 356 |
|
|
2021
Q1 | $32.8M | Sell |
539,158
-1,467,773
| -73% | -$81M | 0.14% | 150 |
|
|
2020
Q4 | $107M | Sell |
2,006,931
-328,494
| -14% | -$17M | 0.47% | 30 |
|
|
2020
Q3 | $110M | Buy |
2,335,425
+199,206
| +9% | +$10.2M | 0.43% | 39 |
|
|
2020
Q2 | $111M | Buy |
2,136,219
+478,280
| +29% | +$24.7M | 0.56% | 34 |
|
|
2020
Q1 | $79.5M | Buy |
1,657,939
+1,112,180
| +204% | +$57.7M | 0.51% | 37 |
|
|
2019
Q4 | $27.6M | Buy |
545,759
+211,446
| +63% | +$10.9M | 0.09% | 263 |
|
|
2019
Q3 | $15.8M | Buy |
334,313
+197,391
| +144% | +$9.01M | 0.06% | 387 |
|
|
2019
Q2 | $6.45M | Buy |
136,922
+22,943
| +20% | +$1.06M | 0.02% | 844 |
|
|
2019
Q1 | $5.49M | Buy |
113,979
+11,615
| +11% | +$582K | 0.02% | 869 |
|
|
2018
Q4 | $4.57M | Sell |
102,364
-345,823
| -77% | -$18M | 0.02% | 818 |
|
|
2018
Q3 | $24.2M | Buy |
448,187
+246,418
| +122% | +$12.6M | 0.09% | 253 |
|
|
2018
Q2 | $9.85M | Buy |
201,769
+101,341
| +101% | +$5.75M | 0.04% | 591 |
|
|
2018
Q1 | $6.3M | Buy |
+100,428
| New | +$6.89M | 0.03% | 726 |
|
Other funds holding CAH
VCM
VPM
Man Group's CAH Position: Q1 2026 in Review
Man Group reduced its Cardinal Health (CAH) stake by 8.3% in Q1 2026, selling an estimated $18.3M and leaving 935,759 shares worth $198M. The position accounts for 0.36% of the portfolio, ranked #47.
Man Group first reported a position in CAH in Q1 2018 and has held it in 30 quarters since. The position peaked at $252M in Q3 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Man Group held 935,759 shares of Cardinal Health worth $198M as of Q1 2026.
- Man Group sold 85,036 Cardinal Health shares in Q1 2026, an estimated $18.3M.
- Cardinal Health made up 0.36% of Man Group's portfolio in Q1 2026, its #47 holding.
- Man Group first reported a position in Cardinal Health in Q1 2018 and has held it in 30 quarters since.
- Man Group's Cardinal Health position peaked at $252M in Q3 2025.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.